On May 11, 2016, Quorum stated its 2016 guidance revenues ranging between $2.2 billion to $2.3 billion. On August 10, 2016, Quorum said it had a damage of $250.4 million during the quarter ending June 30, 2016 and then decreased its 2016 guidance revenues ranging $2.15 billion to $2.20 billion. Following this news, Quorum stock dropped during intraday trading on August 11, 2016.
If you purchased Quorum shares on or before August 10, 2016 or if you are aware of any facts relating to this investigation, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/qhc. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-quorum-health-corporation-qhc-300312673.html
SOURCE Bronstein, Gewirtz & Grossman, LLC